Month: June 2024

Michigan Hospitals, Former Lawmaker Target State Contract Pharmacy Protection Bill Ahead of Summer Recess

June 25, 2024 Shannon Young, Associate Editor/Senior Writer Views

A bill that would enact contract pharmacy protections in Michigan has garnered renewed attention from 340B supporters and critics, alike, in the final days before the state’s legislature is set to recess for the summer.

A bill that would enact contract pharmacy protections in Michigan has garnered renewed attention from 340B supporters and critics, alike, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

PhRMA Asks Federal Judge to Block Enforcement of Maryland’s New 340B Contract Pharmacy Access Law

June 25, 2024 William Newton, Associate Editor/Senior Writer Views

PhRMA filed suit against Maryland's 340B contract pharmacy access law in a federal district court.

A powerful brand-name drug industry trade organization has asked a federal district judge to block Maryland from enforcing the state’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly Adds Significant New Restrictions on 340B Contract Pharmacy Access; Alleges Lack of Oversight by HRSA, Pharmacies and TPAs

June 21, 2024 Bella Czajkowski, National Correspondent & Ted Slafsky, Publisher & CEO Views

Pharmaceutical giant Eli Lilly has significantly escalated its restrictions on access to 340B pricing in the contract pharmacy setting, the company announced June 19 on the drug industry vendor site 340B ESP.

Pharmaceutical giant Eli Lilly has significantly escalated its restrictions on access to 340B pricing in the contract pharmacy setting, the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly Posts 340B Refund Notice for Insulin Product Humulin

June 21, 2024 Bella Czajkowski, National Correspondent Views

Eli Lilly and Amgen announced refunds for 340B covered entities that purchased certain drugs in 2021.

Drug manufacturer Eli Lilly announced a new round of refunds for Humulin, a brand-name insulin, following a 340B ceiling price [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

It’s Official: Long-Awaited Final 340B ADR Rule Takes Effect, But Findings Still Distant

June 21, 2024 William Newton, Associate Editor/Senior Writer Views

The U.S. Department of Health and Human Services' final 340B Administrative Dispute Resolution rule formally took effect on June 18.

Fourteen years after the Congressional deadline, the long-anticipated revision to the 340B Administrative Dispute Resolution (ADR) process officially took effect [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate Companion Bill Introduced to Expand 340B Eligibility to Certain Rural, Outpatient Hospitals

June 21, 2024 William Newton, Associate Editor/Senior Writer Views

Sen. Gary Peters (D-Mich.) introduced companion legislation to a House bill that would extend 340B eligibility to certain rural, emergency hospitals.

A U.S. senator introduced a bill to extend 340B eligibility to certain outpatient rural hospitals with emergency services, mirroring a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CBO Analysts Say Drug Spending Through 340B Grew 19% Annually From 2010 to 2021, 340B Champion Points Finger at Drug Industry

June 21, 2024 Shannon Young, Associate Editor/Senior Writer Views

Spending on pharmaceuticals in the 340B drug discount program went from nearly $7 billion in 2010 to $44 billion by 2021—a 19% annual increase—according to preliminary Congressional Budget Office estimates released this week.

Spending on pharmaceuticals in the 340B drug discount program went from nearly $7 billion in 2010 to $44 billion by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GAO Reissues Recommendations to Improve 340B Compliance, Medicare Financial Stability

June 21, 2024 Shannon Young, Associate Editor/Senior Writer Views

The Government Accountability Office this month recommended that HHS and Congress take long-proposed actions to better ensure 340B program compliance and Medicare’s financial stability.

HHS and Congress should each take long-proposed actions—including a contentious action to curb certain Part B prescribing incentives—to better ensure [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Higher Court Already Rejected AstraZeneca’s Claim on Arkansas 340B Contract Pharmacy Law, State Attorney Tells Federal Judge

June 21, 2024 William Newton, Associate Editor/Senior Writer Views

The Arkansas Insurance Department filed a June 17 motion asking the U.S. District Court for Eastern Arkansas to dismiss AstraZeneca’s claim that Arkansas’ 340B contract pharmacy access law is preempted by the federal 340B statute.

A key argument in AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law has already been rejected by a higher [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospital Groups Bash Novartis’ ‘Whiplash-Inducing’ Arguments in Mississippi 340B Contract Pharmacy Lawsuit

June 21, 2024 William Newton, Associate Editor/Senior Writer Views

AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”

Drug manufacturer Novartis uses contradictory, “whiplash-inducing” arguments in its lawsuit challenging Mississippi’s 340B contract pharmacy law, hospital groups told a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live